Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prostatic carcinoma. Screening--when and what?].

F Recker1, G Lümmen

  • 1Urologische Klinik, Kantonsspital Aarau. franz.recker@ksa.ch

Therapeutische Umschau. Revue Therapeutique
|February 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contemporary perspectives and debates in student ultrasound education: exploring didactic elements and theoretical aspects.

BMC medical education·2026
Same author

Breast assessment using next generation handheld ultrasound device based on silicon chips: a pilot study in senology.

Archives of gynecology and obstetrics·2026
Same author

Assessment of Cyclic Alternating Pattern of sleep during late pregnancy.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Design and implementation of a microlearning-based OSCE preparatory curriculum in obstetrics: a pilot study.

Archives of gynecology and obstetrics·2025
Same author

Teledidactic Versus Hands-on Teaching of Abdominal, Thoracic, and Thyroid Ultrasound-The TELUS II Study.

Journal of general internal medicine·2024
Same author

Shaping the future of obstetric/gynecological ultrasound training.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2023
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Prostate cancer screening using prostate specific antigen (PSA) and digital rectal examination (DRE) significantly increases detection rates. Guidelines recommend screening for men aged 50-70, or 45 with a family history.

Area of Science:

  • Urology
  • Oncology
  • Medical Diagnostics

Context:

  • Prostate cancer is the most common cancer in men and a leading cause of cancer death.
  • Early detection is crucial for curative treatment, which is only possible in organ-confined disease.
  • Prostate-specific antigen (PSA) testing and digital rectal examination (DRE) are key diagnostic tools.

Purpose:

  • To outline the current understanding and recommendations for prostate cancer screening.
  • To define diagnostic thresholds for prostate-specific antigen (PSA) levels and their implications for biopsy.
  • To establish age and risk factor-based screening guidelines.

Summary:

  • PSA and DRE increase prostate cancer detection rates.
  • PSA levels > 4 ng/ml warrant prostate biopsy; levels > 10 ng/ml reduce curative therapy success rates.

Related Experiment Videos

  • Screening is recommended for men aged 50-70, or 45 with a family history, with no evidence that early detection exclusively finds insignificant cancers.

    • Impact:

    • Informs clinical practice regarding prostate cancer screening protocols.
    • Highlights the importance of PSA and DRE in early prostate cancer diagnosis.
    • Provides evidence-based recommendations for age and family history in screening decisions.